Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.
Kai Lipinski
Advertisement
Kai Lipinski, PhD, is the chief scientific officer of Vibalogics.
Articles by Kai Lipinski
Advertisement
Latest Updated Articles
Scaling Manufacturing Processes Using Single-Use TechnologiesPublished: May 15th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
